Cathérine Dubos

685 total citations
5 papers, 73 citations indexed

About

Cathérine Dubos is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Cathérine Dubos has authored 5 papers receiving a total of 73 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 1 paper in Pharmacology. Recurrent topics in Cathérine Dubos's work include Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Genomics and Diagnostics (1 paper). Cathérine Dubos is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Genomics and Diagnostics (1 paper). Cathérine Dubos collaborates with scholars based in France and Switzerland. Cathérine Dubos's co-authors include Benjamin Besse, Colin R. Lindsay, Éric Dansin, Julien Mazières, Nicolas Girard, Jordi Remón, Éric Pichon, J.‐F. Brun, Julie Prévost and P Rousselot and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Thoracic Oncology and Lung Cancer.

In The Last Decade

Cathérine Dubos

5 papers receiving 72 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathérine Dubos France	5	45	33	24	16	10	5	73
Ilona Dahmen Germany	3	19 0.4×	21 0.6×	14 0.6×	12 0.8×	3 0.3×	3	86
Francesca Massaro Italy	6	19 0.4×	17 0.5×	52 2.2×	20 1.3×	10 1.0×	7	105
Alexander Kaplan United States	4	10 0.2×	28 0.8×	27 1.1×	36 2.3×	43 4.3×	5	87
T Tsirlis United Kingdom	4	32 0.7×	35 1.1×	16 0.7×	33 2.1×	9 0.9×	8	96
Eugene Connolly United Kingdom	6	23 0.5×	13 0.4×	23 1.0×	15 0.9×	19 1.9×	7	128
Francesca Plastino France	5	6 0.1×	31 0.9×	16 0.7×	14 0.9×	12 1.2×	15	66
J. Abeillon France	5	15 0.3×	19 0.6×	38 1.6×	2 0.1×	5 0.5×	10	60
Michaela Čepelová Czechia	5	29 0.6×	22 0.7×	4 0.2×	22 1.4×	4 0.4×	18	104
Khizar R. Nandoliya United States	4	18 0.4×	7 0.2×	9 0.4×	4 0.3×	17 1.7×	24	58
Michael Ho United States	3	30 0.7×	6 0.2×	7 0.3×	5 0.3×	36 3.6×	3	90

Countries citing papers authored by Cathérine Dubos

Since Specialization

Citations

This map shows the geographic impact of Cathérine Dubos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathérine Dubos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathérine Dubos more than expected).

Fields of papers citing papers by Cathérine Dubos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathérine Dubos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathérine Dubos. The network helps show where Cathérine Dubos may publish in the future.

Co-authorship network of co-authors of Cathérine Dubos

This figure shows the co-authorship network connecting the top 25 collaborators of Cathérine Dubos. A scholar is included among the top collaborators of Cathérine Dubos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathérine Dubos. Cathérine Dubos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Tison, Alice, Gilles Quéré, L. Misery, et al.. (2018). OP0196 Safety and efficacy of immune checkpoint inhibitors in patients with cancer and preexisting autoimmune diseases: a nationwide multicenter retrospective study. Annals of the Rheumatic Diseases. 77. 147–147. 6 indexed citations

2.

Johnson, Alison, Pascal Dô, Nicolas Richard, et al.. (2016). Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA. Lung Cancer. 99. 38–40. 8 indexed citations

3.

Remón, Jordi, Nicolas Girard, Julien Mazières, et al.. (2016). Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network. Lung Cancer. 97. 99–104. 47 indexed citations

4.

Bylicki, Olivier, Céline Ferlay, C. Chouaïd, et al.. (2013). Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study. Journal of Thoracic Oncology. 8(7). 906–914. 5 indexed citations

5.

Dubos, Cathérine, Julie Prévost, J.‐F. Brun, & P Rousselot. (1991). [Myocardial infarction and vinorelbine. Report of a case].. PubMed. 8(3). 299–300. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact